Reintroduction of palliative intent FOLFIRINOX chemotherapy in a real world pancreatic cancer cohort
27 Mar 2025, 4 p.m.
Publication date: Available online 27 March 2025Source: PancreatologyAuthor(s): A.A. van ...
31st Oct 2019
Despite advances in cancer survival, more than 90 percent of people with pancreatic cancer die within five years. Most patients with pancreatic tumors (and half of those with colorectal cancers) carry a mutation in the KRAS gene, which normally controls cell growth and death.